A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients.
Rossi S, Tatangelo V, Dichiara M, Butini S, Gemma S, Brogi S, Pasquini S, Cappello M, Vincenzi F, Varani K, Lopresti L, Malchiodi M, Carrara C, Gozzetti A, Bocchia M, Marotta G, Patrussi L, Carullo G, Baldari CT, Campiani G.
Rossi S, et al. Among authors: campiani g.
Biomed Pharmacother. 2024 May;174:116537. doi: 10.1016/j.biopha.2024.116537. Epub 2024 Apr 4.
Biomed Pharmacother. 2024.
PMID: 38579402
Free article.